Autophagy is implicated in adaptive response of cells to provide nutrients and energy upon exposure to stress conditions. Cancer cells are known to undergo various forms of stress, including oncogenic (Ras signaling), metabolic (hypoxia and starvation), and therapeutic (drug treatment) stress, and are dependent on autophagy to clear damaged structures, and to restore metabolic and homeostatic balance. Inhibition of autophagy by siRNA and lysosomal inhibitors (e.g. hydroxychloroquine) has been associated with anti-tumor activities in preclinical models and in the clinic. We are currently engaged in developing tools to selectively regulate autophagy in cancer cells.